Back to feed
LGNDLIGAND PHARMACEUTICALS INC
CIK 0000886163 · no recent filings · 0 insider transactions
Buy volume
$0
0 buy transactions
Sell volume
$0
0 sell transactions
Net flow
+$0
Net buying
Total flow
$0
0 priced transactions
Disclosure radarcross-source convergence
Institution-led2/5 sources
18/100
Recent disclosures · timeline
- 8-K1.012.033.028.019.013d ago
Entry into a material agreement
Price · LGND
Live chart by TradingViewLive chart via TradingView. Insider trade price and date are from the underlying SEC filing. Not financial advice.
Material events · 8-K
LGND corporate events · live SEC data- 1.012.033.028.019.01Material3d ago
Entry into a material agreement; Creation of a direct financial obligation
Form 8-K — items reported: 1.01 Entry into a material agreement; 2.03 Creation of a direct financial obligation; 3.02 Unregistered sale of equity securities; 8.01 Other events; 9.01 Financial statements and exhibits.
Item 1.01 · Entry into a material agreement +4 moreView 8-K on EDGAR ↗
Institutional holders · 13F
Q1 2026 vs Q4 2025 · live SEC data5 funds hold$1.26B reported valueNet accumulating(4 adding · 2 reducing)
| Fund | Shares | Value | % of portfolio | QoQ |
|---|---|---|---|---|
| BlackRock Inc | 2,961,923 | $591.35M | 0.0% | Add+1% |
| Vanguard Group Inc | 2,073,892 | $392.11M | 0.0% | Trim |
| State Street Corp | 778,856 | $155.50M | 0.0% | Add |
Recent insider transactions
No insider transactions recorded for LGND.